In this quarterly strategy report, we look to evaluate where we are with regards the bull market conditions, and where those indicators might be headed, factoring in the downside risks, from Trump tariffs and the US economy, BoJ actions, Japanese earnings and valuations.
Having started FY24 with its strongest Q1 yet, healthcare equipment provider Sysmex continued its impressive earnings performance into the Q2. Analyst Nia Dokova views the full-year guidance as conservative as the firm is making progress in the shift to direct sales in the Americas and EMEA.
When the BoJ raised rates in March, it had been 17 years since it had last done so, though the world was very different then. While the July rate hike was unlikely to move the economic needle, the question now is what else might follow the subsequent financial market maelstrom. Pelham Smithers discusses the outlook for Japan’s macro environment, what new fiscal policies the new PM might introduce, how the BoJ might react and the all-important trend in corporate earnings. This then leads us to...
Since the end of 2021, Sysmex’s shares have declined by almost half and are now back to where they were in 2015. The stock is trading at a slight premium to the market, and there is some risk that the firm doesn’t quite deliver on the punchy sell-side earnings expectations. However, if, as we expect, it gets close, then that should at least justify what premium still exists.
With the shares down 41% YTD, Pelham Smithers flags test equipment maker Sysmex as a weak yen beneficiary. Moreover, while Covid has been something of a mixed blessing for the firm, even if Covid-related testing slows, it probably frees up resources elsewhere in the healthcare market, which would lead to increased testing elsewhere. Valuations are also less demanding than global peers.
The independent financial analyst theScreener just lowered the general evaluation of SYSMEX (JP), active in the Medical Equipment industry. As regards its fundamental valuation, the title now shows 0 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date March 25, 2022, the closing price was JPY 9,046.00 and...
The independent financial analyst theScreener just requalified the general evaluation of OMRON (JP), active in the Electronic Equipment industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date January 21, 2022, the clo...
Full Article at IIR has reaffirmed its Recommended rating for PIA after undertaking a review post the appointment of a new Portfolio Manager, Harding Loevner. The full report can be found on the IIR website. On 26 July 2021, Pengana International Equities Limited (PIA) announced a fully franked dividend of 1.35 cents per share for the June quarter. This represents an 8% increase on the March quarter dividend and takes the total dividends declared for FY21 of 5.1 cents per share, fully franked....
Summary Marketline's National OilWell Varco, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by National OilWell Varco, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive break...
Summary Marketline's Murata Manufacturing Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Murata Manufacturing Co., Ltd. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive ...
Health Care outperforming globally -- overweight; India breaking out -- add exposure With the primary global ex-U.S. indexes MSCI EAFE, MSCI EM, and MSCI ACWI ex-U.S. continuing their sideways to downward consolidation from a price perspective, the importance of Sector, Group, and stock selection is critical. • Sector and Group Opportunities. Today we put the spotlight on the Health Care Sector, which is assuming a global leadership role as it separates itself from the other international Se...
KYOTO, Japan--(BUSINESS WIRE)-- OMRON Corporation today announced its consolidated operating results for the first quarter of fiscal 2018, ending June 30, 2018. Net sales increased 3.1%, to ¥209.8 billion, while gross profit rose 4.3%, to ¥87.7 billion; both new record highs for OMRON. These results boosted the gross profit margin by 0.5 percentage point, to 41.8%, also a record for a fiscal first quarter. Operating income declined 13.6%, to ¥19.6 billion, while net income attributable to shareholders contracted 5.4%, to ¥14....
The U.S. has continued to separate itself from broad emerging market and developed international indexes. Thankfully, one positive is that MSCI EM and MSCI EAFE have been able to stabilize from a price perspective despite relative strength weakness vs. MSCI ACWI... see charts below. In today's report we scour the globe for attractive investments in an environment where selectivity is key. • Emerging markets. There is still not much to like about broad EM as the MSCI Emerging Markets index ...
KYOTO, Japan--(BUSINESS WIRE)-- OMRON Corporation (TOKYO:6645) today announced its consolidated operating results for fiscal 2017, ended March 31, 2018. Companywide growth in the core Industrial Automation and Healthcare businesses resulted in net sales rising 8.3% from a year earlier, to JPY860.0 billion. Gross profit increased 14.7%, to JPY357.7 billion, operating income advanced 27.1%, to JPY85.9 billion, and net income attributable to shareholders jumped 37.3%, to JPY63.2 billion, a record for the Company. Gross profit wa...
KYOTO, Japan--(BUSINESS WIRE)-- OMRON Corporation (TOKYO: 6645) today announced its consolidated operating results for the first nine months of fiscal 2017, ended December 31, 2018. Net sales for the term advanced 9.9% from a year earlier, to JPY624.9 billion, reflecting progress in the core Industrial Automation Business (“IAB”), as well as in the Electronic and Mechanical Components Business and the Healthcare Business. Gross profit rose 16.4%, to JPY260.8 billion, operating income climbed 40.5%, to JPY64.4 billion, and net income a...
Big-picture technicals offer a compelling outlook for equities -- in the long-run. Despite arguably stretched trends, especially in the U.S. and EM, one indicator in particular keeps us optimistic: monthly charts. What is likely the least-used timeframe, monthly charts (> 20 years) offer the most clarity. And what's clear right now is: (1) Europe is on the doorstep of breaking above secular resistance; (2) Japan is breaking out above secular resistance; (3) and EM already has. Speaking of EM, w...
KYOTO, Japan--(BUSINESS WIRE)-- OMRON Corporation (TOKYO:6645) (Headquarters: Shimogyo-Ku, Kyoto. President and CEO: Yoshihito Yamada) today announced its consolidated operating results for the first half of fiscal 2017, ended September 30, 2017. Net sales for the period increased 10.5%, to JPY410.5 billion. Net income attributable to shareholders jumped 91.2%, to JPY30.3 billion. The primary growth driver was factory automation. Sales of that business climbed 22.5% from a year earlier, to JPY193.5 billion and operating ...
KYOTO, Japan--(BUSINESS WIRE)-- OMRON Corporation (TOKYO: 6645) (HQ: Shimogyo-Ku, Kyoto, Japan. President and CEO: Yoshihito Yamada) today announced its consolidated operating results for the first quarter of fiscal 2017, ending June 30, 2017. Net sales increased 10.2%, to ¥203.4 billion, gross profit increased 18.7%, to ¥84.1 billion, and operating income climbed 130.8%, to ¥22.6 billion. Net income attributable to shareholders advanced 95.8%, to ¥15.5 billion. Gross profit, operating income and net income are all rec...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.